Market Place
Sourcing Support
All News #Library
Biotech
Alzamend Neuro Reports Positive Phase II Data for AL001
07 Apr 2026 //
PR NEWSWIRE
Alzamend AL001 Shows Bioequivalence, Better Brain Delivery
26 Mar 2026 //
PR NEWSWIRE
Alzamend Neuro Starts Phase 2 Trial Of AL001 For Bipolar Disorder
16 Mar 2026 //
PR NEWSWIRE
Alzamend Neuro to Speak at 2025 Military Health Symposium
28 Jul 2025 //
GLOBENEWSWIRE
Alzamend Neuro to Start Phase II Trial of AL001 at Hospital
11 Mar 2025 //
GLOBENEWSWIRE
Alzamend Neuro To Start Ph II AL001 Trial At Mass General Hospital
25 Feb 2025 //
GLOBENEWSWIRE
Alzamend Neuro Announces the Initiation of a Phase I/IIA Trial for ALZN002
03 Apr 2023 //
BUSINESSWIRE
Alzamend Partners With Biorasi to Conduct a Parallel Group Phase I/IIA Trial
04 Jan 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.